A man has been hospitalised following a serious assault in the early hours of Wednesday morning. Police were called to Cathedral Road in Cardiff following reports of an assault at around 2.30am.

A 57-year-old man was found injured at the scene and taken to hospital by paramedics from the Welsh Ambulance Service. A 41-year-old woman was then arrested on suspicion of wounding with intent and assaulting an emergency worker.

Emergency services closed the Esso petrol station on Cathedral Road for around five hours and officers urged the public to avoid the area. The road and petrol station had fully reopened by 8am.

A South Wales Police spokesperson said: “South Wales Police is investigating an assault reported at around 2.30am this morning in Cathedral Road, near the Esso garage, Pontcanna, Cardiff.

“A 57-year-old man was taken to the University Hospital of Wales, Cardiff, where he continues to receive medical treatment.

“A 41-year-old woman was arrested on suspicion of wounding with intent and assaulting an emergency worker.

“Those involved are known to each other and inquiries are on-going.”

Dean Midas, the independent County Durham filmmaker behind the ‘Midas-Verse,’ will direct a short film adaptation of Northumberland author Neale Carter’s book, A Warning To Those Who Refute the Dark.

The announcement comes after Mr Midas’ recent success with his festive horror short, Christmas Eve, which went viral and achieved more than 50,000 views on YouTube.

Mr Midas said: “Adapting Neale Carter’s work is a thrilling next step.

“Whether it’s the viral reach of Christmas Eve, the upcoming release of The Stitcher, or the return of the Masquerade Ball, it’s all about creating experiences that resonate with the audience.

The film is an adaptation of Neale Carter’s book, A Warning To Those Who Refute the Dark (Image: Supplied)

“I can’t wait to bring this new, dark vision to the screen.”

READ MORE: Darlington mum’s fury after son’s school ‘didn’t tell her that he had escaped’
READ MORE: Breast cancer patient says treatment ordeal left her feeling she had ‘no dignity’
READ MORE: Darlington businesses left ‘unable to take payments’ as phone signal outage continues

Mr Carter, who lives in Northumberland, said he aimed to instil “a sense of lingering dread” in his writing.

He said: “Dean’s work in the ‘Midas-Verse’ has that exact same visceral, atmospheric energy, and I couldn’t be more thrilled to see how he translates my words into a terrifying cinematic experience.”

Further details regarding the production schedule, casting, and release plans for the adaptation will be shared in the coming months.

In The Mixer’s World Cup special

Everything you need to know about the World Cup – England updates, the games to watch and stories you missed – in five minutes, at 1pm, every day.

More than 2,200 patients were subjected to corridor care in A&E every day in May, new NHS data has revealed.

The figures have been revealed for the first time after the NHS pledged to publish data on corridor care in hospitals.

Any patient who spends 45 minutes or more in areas of emergency departments or wards deemed as clinically inappropriate – such as hallways or waiting rooms – are considered to have experienced corridor care, according to the NHS.

The first figures to be published show that, on average, 2,241 patients each day experienced corridor care in emergency departments last month, while a further 669 patients received care in similar settings elsewhere in hospital.

Hallways, cafes, cupboards and waiting rooms are some of the unsuitable locations sick patients have been treated in overwhelmed A&E departments.

Corridor care “should never have been normalised,” Siva Anandaciva, director of policy at The King’s Fund said highlighting that patients are routinely being treated “without privacy or dignity.”

“Corridor care is one of the most visible signs of how patient safety and experience are being compromised in the NHS. It is distressing for staff when they cannot deliver the care they want for their patients and it is equally unacceptable when patients are left feeling forgotten and vulnerable at the time they most need to feel safe and cared for,” he added.

NHS analysis found that 20 trusts accounted for more than half of the cases of corridor care in emergency departments and it is now aiming to eliminate the “unacceptable” practice of treating patients in corridors in busy A&E departments.

It comes after reports of patients dying while waiting for care and diabetic patients left for hours without food.

Other sick patients have said they were left on broken beds in pitch-black corridors for 24 hours with no privacy, according to a review of patient care in emergency departments in December by the group Healthwatch England.

“Corridor care is unacceptable, undignified and has no place in our NHS,” health secretary James Murray said.

He said the new data aims to “shine a spotlight” on where the problems are greatest and stressed the “vast majority” of corridor care is in a small number of organisations.

“We have already deployed expert teams to help struggling trusts turn performance around. Ending corridor care for good will take time, and different areas will need different solutions, but we are determined to eradicate this practice,” he added.

A&Es experienced their busiest month on record in May with 2,457,398 attendances – up 25,000 on the previous record set in March earlier this year.

The number of people waiting more than 12 hours in A&E departments in England from a decision to admit to actually being admitted stood at 50,212 in May, up from 47,750 in April. The figure reached a record 71,517 people in January.

The number waiting at least four hours from the decision to admit to admission stood at 128,590 last month, up from 122,616 in April.

Some 75.7 per cent of patients in England were seen within four hours in A&Es in May, down from 76.9 per cent in April.

The government and NHS England had set a target of March this year for 78 per cent of patients attending A&E to be admitted, discharged or transferred within four hours.

Meanwhile, the waiting list for routine hospital treatment in England has risen for the first time in six months.

An estimated 7.22 million treatments were waiting to be carried out at the end of April, relating to 6.11 million patients, NHS figures show.

This is up from 7.11 million treatments and 6.02 million patients at the end of March.

The increase means the size of the list has returned to where it stood in February, reversing the fall that took place in March.

“A&E staff bore the brunt of the heatwave in May, as the hot weather took its toll on the public,” Professor Francesca Swords, national medical director for the NHS explained.

“In the face of record demand during the recent heatwave, NHS staff rose to the challenge, ensuring that as many patients as possible were seen and treated in good time,” she said.

She added that corridor care is “totally unacceptable” and “should have no place in the NHS.”

This story is being updated.

“I am proud of what we have done in less than two years as a Labour Government. We’ve stepped up to lead internationally for Ukraine with the Coalition of the Willing and Ukraine Defence Contact Group, established Britain as a leading voice for Europe in Nato, raised defence investment to 2.5 per cent of GDP three years earlier than anyone expected, launched the deepest defence reforms in 50 years, won the biggest UK defence export deals for decades, published a first-of-its-kind Strategic Defence Review (SDR), gave our Armed Forces the biggest pay rise in nearly 20 years, boosted military morale, fixed over 1,200 of the worst forces family homes, reset relations with European allies and signed major defence agreements with Germany, Norway and France.

The UK Health Security Agency has issued an urgent plea to parents

Health officials have issued a warning to parents after two children in England have died from measles this year.

Experts at the UK Health Security Agency (UKHSA) have urged all parents to ensure their children are up to date with their MMR (measles, mumps and rubella) or MMRV vaccines as the potentially life-threatening illness continues to circulate in many parts of the country.

There have been 736 cases so far this year, compared with 959 cases for the whole of 2025, new figures show, with many of the cases linked to outbreaks in London and the West Midlands.

Click here to get the biggest stories straight to your inbox in our Daily Newsletter

The UKHSA said the majority of cases were among unvaccinated children aged 10 and under. Two measles deaths have been reported this year; one child died from ‘acute measles’ and another child’s death was linked to the ‘late effects of measles’, the UKHSA said.

The agency added that in the last month, cases have been confirmed in London, the East of England and the West Midlands.

Dr Vanessa Saliba, consultant epidemiologist at UKHSA, said: “Our thoughts and condolences are with the families who have so tragically lost their children.

“Measles continues to circulate in many parts of the country and as we have seen it can be very serious and even fatal.

“We urge all parents to ensure their children are up to date with their MMR or MMRV vaccines, giving them the best and safest protection against measles – which can spread very easily.

“Anyone who has missed out on their measles vaccines can catch up through their GP practice whatever their age.

“Getting vaccinated also helps protect babies who are too young to be vaccinated and people unable to have the vaccine due to a health condition. Please don’t delay and if you or your child are not up to date, book an appointment today.”

Measles is a highly infectious viral illness that can spread very easily among people who are not fully vaccinated. While many people recover, the illness can lead to serious complications such as pneumonia, brain inflammation and, in rare cases, long-term disability or death.

Health Secretary James Murray said the latest measles deaths are a “heartbreaking reminder that measles is not a harmless childhood illness”.

He said: “My thoughts are with the families who have suffered such unimaginable loss. These deaths are a heartbreaking reminder that measles is not a harmless childhood illness.

“Measles can lead to serious complications that can be fatal, and the MMR vaccine, which has saved countless lives, remains the best protection we have against this highly infectious disease.

“I urge all parents and carers to check that their children are up to date with their vaccinations as it is never too late to catch up – even if you miss a dose.

“By ensuring our children are vaccinated, we not only protect them but also help safeguard the most vulnerable in our communities.”

It comes after the World Health Organisation (WHO) announced that the UK is no longer considered to have eliminated measles earlier this year, following a plateau in vaccination coverage and a surge in cases.

The latest data shows that 91.8 per cent of five-year-olds had received one dose of the MMR vaccine in England in 2024/25, unchanged from 2023/24 and the lowest level since 2010/11.

The broadcaster has adjusted its schedule throughout the week to accommodate major international football broadcasts.

Tuesday (June 9) saw Coronation Street and Emmerdale replaced by the Women’s European Qualifier between England and Ukraine.

The soaps then aired at an earlier time on Wednesday (June 10) due to England’s Men’s World Cup warm-up match against Costa Rica.

Heads up! ⚽️ Here’s where to find us this week.

Don’t forget, you can catch us at 7am on ITVX and YouTube 🎉#Corrie #Emmerdale pic.twitter.com/QuiLDLLv0b

— Coronation Street (@itvcorrie) June 8, 2026

Why are Coronation Street and Emmerdale not on ITV tonight?

Once again, it is a major sporting event that will keep Coronation Street and Emmerdale off air tonight.

Coverage of the World Cup opening ceremony begins at 6.15pm on ITV1, followed by the tournament’s first match at 7.50pm.

The 2026 World Cup starts on ITV tonight 🤩

It all gets started at 6.15 pm with all the build-up and the opening ceremony! ⚽️ pic.twitter.com/7SJZc90rRt

— ITV Football (@itvfootball) June 11, 2026

As a result, both Coronation Street and Emmerdale have been removed from ITV’s evening schedule.

Soap fans will have to wait until Friday (June 12) for the next episodes.

Emmerdale will return for a full hour at 8pm, with Coronation Street following at 9pm, also for an hour-long episode.

No episodes of the soaps will be available to watch on ITV1 on Sunday (June 14).

Have you noticed ITV’s new scheduling this year?

From January 2026, the broadcaster introduced a “soaps power hour” on weekdays with 30-minute Emmerdale episodes at 8pm and 30-minute Coronation Street episodes at 8.30pm.

Coronation Street previously aired for three hour-long episodes a week, while Emmerdale aired four 30-minute episodes and one hour-long instalment.

Announcing the new schedule last year, ITV’s Managing Director of Media and Entertainment, Kevin Lygo, said: “The new commissioning pattern is viewer-led. 

“We already give more choice than ever to viewers on how they watch us through ITVX and we want to present their favourite soap to them, in the most digestible way.

“In a world where there is so much competition for viewers’ time and attention, and viewing habits continue to change, we believe this is the right amount of episodes that fans can fit into their viewing schedule, to keep up to date with the shows.”

Have these ITV schedule changes disrupted your soap viewing habits this week? Let us know in the comments below.

For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more sessions, Monday to Friday, for a month or longer. A new NHS England programme aims to shrink that burden dramatically by offering eligible men a highly focused form of radiotherapy that treats the cancer in just five sessions.

It sounds almost too good to be true: a comparable chance of controlling the disease, with far fewer visits and much less disruption to work and family life. But five-session treatment can still cause short-term and longer-term side-effects.

So what exactly is changing, and what should men make of it?

A sharper way to deliver radiation

The approach is called stereotactic ablative radiotherapy, or SABR. You may also hear it described as stereotactic body radiotherapy, or SBRT, and more colloquially as “multi-beam” or “high-precision” radiotherapy.

Instead of delivering smaller doses over many sessions, doctors give a higher dose at each appointment while targeting the prostate accurately.

Picture several torches shining from different angles. Each beam is relatively weak, but the light becomes intensely bright where they meet. SABR works in a similar way. Advanced imaging and computer planning map the target area, sometimes using tiny implanted markers as reference points. The machine delivers multiple beams that converge on the prostate, while nearby healthy tissue receives much less radiation.

That precision allows the schedule to shrink from at least 20 daily sessions to five doses within a fortnight. The appointments do not necessarily take place on five consecutive days.

Why NHS England is changing course

Prostate cancer is the most commonly diagnosed cancer in men in the UK, with more than 55,000 diagnoses each year. For men whose cancer is confined to the prostate, surgery or radiotherapy may offer a good chance of cure. Questions about diagnosis and screening remain the subject of active discussion.

Radiotherapy services are under strain, with machines and specialist staff in high demand. NHS England estimates that SABR could eventually be offered to around 17,500 men with low or intermediate-risk prostate cancer each year. These are cancers that have not spread and are considered less likely to grow or spread rapidly.

Around 3,500 men may initially choose SABR. Rolling the treatment out across all 48 radiotherapy providers in England could free approximately 50,000 appointments a year.

The rollout reflects a wider change in the way radiotherapy is delivered. Previous NHS England policies have supported stereotactic radiotherapy in other settings. Over the past decade, evidence from large clinical trials has shown that giving fewer, larger doses of radiation can control prostate cancer as effectively as longer courses in patients for whom the treatment is suitable.

For patients, the benefit is practical: weeks of hospital visits may be condensed into five trips. You lie on a firm couch while a large machine rotates around you. The treatment is painless. Additional imaging and checks are needed, but sessions take minutes rather than hours.

Side-effects and safety

Radiotherapy to the prostate, whether delivered over five sessions or 20, carries risks. The prostate sits in a crowded neighbourhood. The bladder lies just above it, the rectum sits behind it, and the urethra, the tube that carries urine out of the body, runs through the middle.

Men may experience urinary frequency or urgency, a burning sensation when passing urine, loose stools and fatigue. These effects commonly settle over weeks or months. Some develop longer-term problems, including urinary changes, leakage, difficulty with erections or bowel symptoms such as urgency or bleeding.

SABR is designed to limit radiation to surrounding tissue, but it delivers a higher dose at each appointment. Trial evidence suggests that side-effects are broadly comparable to those associated with standard radiotherapy schedules. A five-session course does not eliminate the risk of lasting complications.

SABR is already used to treat small lung tumours and other cancers. In the PACE-B trial, more than 95 out of 100 men in both the five-session group and the standard-treatment group remained free of cancer recurrence five years after treatment. Longer-term follow-up remains important.

SABR will not suit every man. The NHS England rollout is aimed at eligible men with localised low or intermediate-risk disease. A patient’s risk profile, general health and need for additional treatment, including hormone therapy to slow the growth of the cancer, will shape the options offered by his clinical team. Men with higher-risk disease or cancer that has spread may need a different plan.

Not everyone needs immediate treatment

For some men with low-risk, localised prostate cancer, the first decision is not “SABR versus standard radiotherapy”, but “treatment now versus careful monitoring”.

Many prostate cancers grow so slowly that they may never cause problems during a man’s lifetime. Doctors are therefore concerned about overtreatment: operating on or irradiating cancers that would never have harmed the patient.

Active surveillance, a form of careful monitoring, usually involves regular PSA blood tests, which measure the level of prostate-specific antigen in the blood, as well as scans and sometimes biopsies. Treatment is reserved for cancers that become more aggressive.

You may also hear the phrase “watchful waiting”. The terms describe different approaches. Active surveillance preserves the option of treatment intended to cure the cancer if it changes. Watchful waiting usually involves less intensive monitoring and is more commonly recommended when treatment burdens may outweigh the benefits.

SABR does not change that calculation. For some men, surveillance may remain the most appropriate option. For others, SABR offers a shorter way to deliver effective treatment.

A step forward, with limits

SABR should reduce the disruption caused by repeated hospital visits and release badly needed capacity within radiotherapy services. It does not remove the trade-offs between treating cancer and preserving quality of life, and it will not suit every man.

The key is an individualised discussion about the relevant options, including surveillance, surgery, standard radiotherapy and SABR.

For some men, condensing treatment into five hospital visits will be enormously attractive. What this policy shift signals is a quieter revolution in radiotherapy: more time at home, fewer journeys to hospital, and a treatment that tries to hit the cancer harder while hitting the rest of the body a little less.